SERVICES

Archive | Drugs and Pharmaceuticals

Press Release: Florida Attorney General Uthmeier Becomes First in Nation to Subpoena CVS’s Secret Contracts with Drug Manufacturers, Distributors, and Pharmacies

TALLAHASSEE, Fla., June 25, 2026 (SEND2PRESS NEWSWIRE) — Small Business Pharmacies Aligned for Reform (SPAR) today praised Florida Attorney General James Uthmeier for becoming the first attorney general in the United States to subpoena CVS’s confidential contracts with drug manufacturers, wholesale distributors, and both chain and independent retail pharmacies.

Continue Reading

Press Release: HLA Protein Technologies Debuts sHLA-G Monomer and Tetramer Portfolio for High-Fidelity Checkpoint Biology, Target Validation, and Assay Development

OKLAHOMA CITY, Okla., Nov. 19, 2025 (SEND2PRESS NEWSWIRE) — HLA Protein Technologies, Inc. (formerly Pure Protein, LLC) today announced the commercial launch of its new soluble HLA-G (sHLA-G) product portfolio, marking an expansion of its next-generation HLA research tools. HLA-G is a non-classical MHC Class I molecule recognized as a key immune checkpoint regulator.

Continue Reading

Press Release: Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled “Cartridge Devices for Administration of a Medicament” (U.S. Patent No. 12329949) and “Hand-Operated Devices for […]

Continue Reading

Press Release: Zeteo Biomedical Secures Global Patents for Nasal and Ophthalmic Drug Delivery Device Innovations

CEDAR PARK, Texas, June 11, 2025 (SEND2PRESS NEWSWIRE) — Zeteo Biomedical, a privately held biomedical device company, today announced the issuance of new patents in the United States and European Union for its advanced drug delivery technologies. The patents, titled “Cartridge Devices for Administration of a Medicament” (U.S. Patent No. 12329949) and “Hand-Operated Devices for […]

Continue Reading

Press Release: Pain Neuromodulation Market to Reach $6.5 Billion by 2030

SAN FRANCISCO, Calif., March 31, 2025 (SEND2PRESS NEWSWIRE) — Neurotech Reports, the publisher of the newsletter Neurotech Business Report, announced the availability of a new market research report that forecasts the growth of the worldwide market for implanted pain neuromodulation systems. According to the newly published report, “The Market for Implanted Pain Neuromodulation Systems: 2025-2030,” […]

Continue Reading

Press Release: SET Enterprises launches 340b covered entity suspicious purchase identification service for pharmaceutical and biological manufacturers

PHOENIX, Ariz., Aug. 2, 2024 (SEND2PRESS NEWSWIRE) — SET Enterprises, a leading independent management consulting firm serving the government pricing compliance needs of life sciences manufacturers, today announced the launch of SPI340B℠. This new service offering identifies specific 340B covered entities that exhibit suspicious purchasing patterns that suggest the entire volume of products purchased from […]

Continue Reading

Press Release: SET Enterprises launches 340b covered entity suspicious purchase identification service for pharmaceutical and biological manufacturers

PHOENIX, Ariz., Aug. 2, 2024 (SEND2PRESS NEWSWIRE) — SET Enterprises, a leading independent management consulting firm serving the government pricing compliance needs of life sciences manufacturers, today announced the launch of SPI340B℠. This new service offering identifies specific 340B covered entities that exhibit suspicious purchasing patterns that suggest the entire volume of products purchased from […]

Continue Reading

Press Release: Trends in Drug Benefit Design Report Released by Pharmaceutical Strategies Group (PSG)

DALLAS, Texas, June 13, 2023 (SEND2PRESS NEWSWIRE) — Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the launch of its Trends in Drug Benefit Design Report. The report delivers innovative research on the latest trends in the traditional (non-specialty) drug benefit. Sponsored by Rx Savings Solutions, it outlines the complexities of designing […]

Continue Reading

Press Release: PSG Announces Release of Highly Anticipated ‘Trends in Specialty Drug Benefits Report’

DALLAS, Texas, May 1, 2023 (SEND2PRESS NEWSWIRE) — Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual ‘Trends in Specialty Drug Benefits report.’ Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research. PSG has been researching and reporting on drug […]

Continue Reading

Press Release: NEW PRODUCT LAUNCH: Pharmaceutical Strategies Group (PSG) Announces Artemetrx Extend – Revolutionary Drug Management Reporting Tool Offers Powerful User Insights

DALLAS, Texas, Jan. 23, 2023 (SEND2PRESS NEWSWIRE) — Artemetrx®, the industry’s most preeminent platform for integrated drug cost management, is now even more robust with the launch of its new module, Artemetrx Extend™. With greater insights and analytics, Artemetrx Extend is a custom reporting tool that provides unparalleled data access through its user-friendly platform.

Continue Reading

Part of the Neotrope® News Network, USA. Neotrope.net